The U.S. Food and Drug Administration has approved AbbVie Inc <a href="https://www.reuters.com/companies/ABBV.N" target="_blank">(ABBV.N)</a> and Danish drugmaker Genmab's <a href="https://www.reuters.com/companies/GMAB.CO" target="_blank">(GMAB.CO)</a> blood…